Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 3Completed 3Withdrawn 2Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 2Stomatitis 1Sexual Dysfunction, Physiological 1Pruritus 1Prostatic Neoplasms 1Pneumonia 1Pain 1Nevus, Pigmented 1Mucositis 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lung Neoplasms 1Leiomyoma 1Kidney Neoplasms 1Ileus 1Head and Neck Neoplasms 1Feeding and Eating Disorders 1

Interventions

Gemcitabine 34pembrolizumab 27Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Lidocaine × Clear all
NCT04250805 2024-01-31

GASTROXY

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Terminated
17 enrolled

Feeding and Eating Disorders, Neoplasms, Pain

NCT02606994 2019-02-06

TPvsM

Oral Defense, LLC

Phase 2 Terminated
1 enrolled
Other

Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡